Navigation Links
Genstruct Names Louis Latino VP of Sales
Date:9/17/2008

CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, announced today that it has appointed Louis Latino as VP of Sales. As part of Genstruct's executive management team, Mr. Latino will lead the company's global sales efforts, focusing on building the company's sales infrastructure to drive future growth.

In his role as VP of Sales, Mr. Latino will be responsible for managing and expanding partnerships with existing customers while leveraging the Genstruct platform to expand the company's consulting services and partnership business through the development of new partnerships and collaborations within the global biotechnology, pharmaceutical and related industries.

"Earlier this year we launched our Consulting Services division, and we have rapidly grown this business to the point that we need to build a world- class sales team to manage its growth. Lou Latino has both the experience and expertise we need to manage the growth of this business," said Keith O. Elliston, Ph.D., president and CEO of Genstruct. "He is ideally suited to extend the impact of the Genstruct platform throughout the life sciences sector. His wealth of management experience with early-stage companies and his outstanding sales record in the life sciences industry are the key qualities we need to expand our current partnerships and our customer base."

"Genstruct's Causal Network(TM) modeling platform has been vital to the development of safe and effective new drugs for our partners," said Mr. Latino. "As Genstruct's team of scientists and technology experts focus on new approaches to better understand and treat complex diseases, I see this as an opportunity to leverage the company's successes to broaden its impact across the industry."

Mr. Latino has nearly 30 years of senior sales management and direct sales experience. Prior to joining Genstruct, he was VP of North America, Life Sciences Sales and Support for Accelrys, Inc., a developer of a broad range of technologies, including computer-aided-molecular-design and scientific business intelligence software. He honed his life sciences expertise as VP of Worldwide Sales for Geneformatics and as a regional sales manager for Biosym Technologies. In both positions, he exceeded revenue goals and increased profitability for the respective companies, while enhancing the impact of their technologies.

Mr. Latino has also held senior sales positions with Superscape Group, Mitchell Management Systems and BIW Cable Systems. He earned his bachelor's degree in chemistry from Boston College.

About Genstruct

Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assembly, and Epistemics Engine are trademarks of Genstruct, Inc. All other trademarks or registered trademarks are properties of their respective owners.

Contact:

Karen Higgins

A & E Communications for Genstruct

(610) 831-5723

khiggins@aandecomm.com


'/>"/>
SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
7. ThermoGenesis Names Tiffany Olson to Board of Directors
8. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
9. eResearchTechnology Names New Chief Financial Officer
10. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
11. The TPAA Names Mark Oelschlager President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016  BD (Becton, Dickinson and Company) (NYSE: ... announced the launch of the BD CLiC™ System during ... Meeting. --> --> ... providing cost effective NGS library preparation with limited operator ... integrated, next generation sequencing (NGS) library prep instrument, engineered ...
(Date:2/11/2016)... Inc. (NASDAQ: NBIX ) today announced its financial results for ... --> --> For the fourth quarter of ... $0.34 loss per share, compared to a net loss of $19.4 ... 2014. For the year ended December 31, 2015, the Company reported ... as compared to a net loss of $60.5 million, or $0.81 ...
(Date:2/11/2016)... -- Spectra BioPharma Selling Solutions (Spectra) is a new ... the experience, expertise, operational delivery and customer focus ... Created in concert with industry leading commercial experts, ... tactical needs of its clients by providing value-based ... and non-personal promotion. --> ...
(Date:2/11/2016)... BEACH, Florida , February 11, 2016 /PRNewswire/ ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), ... diagnostics, announced today that its Thermomedics subsidiary, which ... progress on its growth plan in January 2016, ... products distributors, increasing sequential monthly sales growth, and ...
Breaking Biology Technology:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
Breaking Biology News(10 mins):